Scoopfeeds — Intelligent news, curated.
Nektar Therapeutics chief R&D officer sells $336,211 in stock
business

Nektar Therapeutics chief R&D officer sells $336,211 in stock

Investing.com · Jun 22, 2026, 4:55 PM · Also reported by 1 other source

Nektar Therapeutics chief R&D officer sells $336,211 in stock

Read full story on Investing.com → More top stories

Also covered by

Aggregated and edited by the Scoop newsroom. We surface news from Investing.com alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop